{"id":"W4398256251","doi":"10.1158/1535-7163.mct-23-0564","title":"PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Golfers Against Cancer; Cancer Prevention and Research Institute of Texas; Breast Cancer Research Foundation; Pfizer; Robert and Janice McNair Foundation; Susan G. Komen for the Cure","keywords":"Palbociclib; Gemcitabine; Breast cancer; Cancer research; Estrogen receptor; Cancer; Tamoxifen; Medicine; Internal medicine; Biology; Oncology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003435303,0.000239616,0.0003025222,0.0006189201,0.0001705033,0.0004261061,0.0001415388,0.0002362295,0.001632088],"category_scores_gemma":[0.0004390616,0.0001604463,0.0001642273,0.0003867248,0.0001970741,0.0002569077,0.0001768635,0.0005009579,0.0003277102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004618618,"about_ca_system_score_gemma":0.0001918192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002375961,"about_ca_topic_score_gemma":0.0002994016,"domain_scores_codex":[0.9997752,0.0000445805,0.00001902842,0.00005841087,0.00007416246,0.00002862948],"domain_scores_gemma":[0.9998006,0.00003607443,0.00009827092,0.00001488453,0.00002082971,0.0000292718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001451395,0.0001054869,0.04300565,0.0001538473,0.00005566461,0.0002956524,0.00005543966,0.0006600033,0.918539,0.000191508,0.0004036015,0.03508274],"study_design_scores_gemma":[0.00005833333,0.001580593,0.2939049,0.00002423194,0.0001034985,0.004373956,0.0001069134,0.003998572,0.6868446,0.000317884,0.008668935,0.00001766532],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888732,0.004583868,0.003304236,0.0001832326,0.00002246258,0.0000556039,0.0007823006,0.0001021194,0.002092997],"genre_scores_gemma":[0.9952945,0.0008678748,0.002105514,0.00003138946,0.00001499958,0.00003289151,0.0005450535,0.00001500673,0.001092755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001632088,"threshold_uncertainty_score":0.005459905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0195323455154225,"score_gpt":0.3185785255817443,"score_spread":0.2990461800663218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}